Jefferson’s Dr. Scott Waldman first had the notion to use a patient’s immune system to fight colorectal cancer in 1993. The idea of using immunotherapy to fight cancers (primarily blood cancers) was in its infancy at the time. Dr. Waldman was encouraged by some of the failures of the blood cancer research, and thought he had an excellent target for immunotherapy — guanylyl cyclase C or GUCY2C (often pronounced “goosy toosy”).